X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (153) 153
hygiene (153) 153
medical or veterinary science (153) 153
preparations for medical, dental, or toilet purposes (151) 151
chemistry (129) 129
metallurgy (129) 129
organic chemistry (129) 129
peptides (128) 128
specific therapeutic activity of chemical compounds ormedicinal preparations (104) 104
humans (20) 20
baby comforters (19) 19
containers specially adapted for medical or pharmaceuticalpurposes (19) 19
devices for administering food or medicines orally (19) 19
devices for receiving spittle (19) 19
devices or methods specially adapted for bringingpharmaceutical products into particular physical oradministering forms (19) 19
male (17) 17
female (16) 16
middle aged (15) 15
double-blind method (14) 14
cardiac & cardiovascular systems (13) 13
treatment outcome (13) 13
cholesterol (12) 12
adult (11) 11
cardiovascular (11) 11
cholesterol, ldl - blood (11) 11
drug therapy, combination (11) 11
hypercholesterolemia (11) 11
hypercholesterolemia - drug therapy (11) 11
monoclonal antibodies (11) 11
alirocumab (10) 10
abridged index medicus (9) 9
aged (9) 9
atorvastatin (9) 9
pcsk9 (9) 9
therapy (9) 9
antibodies, monoclonal - administration & dosage (8) 8
efficacy (8) 8
lipids (8) 8
monoclonal-antibody (8) 8
safety (8) 8
antibodies, monoclonal - therapeutic use (7) 7
atorvastatin calcium (6) 6
cardiovascular disease (6) 6
cardiovascular diseases - prevention & control (6) 6
density-lipoprotein cholesterol (6) 6
disease (6) 6
hypercholesterolemia - blood (6) 6
internal medicine (6) 6
low density lipoprotein (6) 6
low density lipoproteins (6) 6
statins (6) 6
acute coronary syndromes (5) 5
analysis (5) 5
antibodies, monoclonal - adverse effects (5) 5
anticholesteremic agents - administration & dosage (5) 5
anticholesteremic agents - therapeutic use (5) 5
cardiovascular diseases (5) 5
care and treatment (5) 5
drug therapy (5) 5
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (5) 5
lipoproteins (5) 5
proprotein convertase 9 (5) 5
proprotein convertases - antagonists & inhibitors (5) 5
cardiology and cardiovascular medicine (4) 4
clinical trials (4) 4
diabetes (4) 4
dose-response relationship, drug (4) 4
ezetimibe (4) 4
follow-up studies (4) 4
heart attacks (4) 4
heptanoic acids - administration & dosage (4) 4
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (4) 4
low-density lipoprotein cholesterol (4) 4
medicine, general & internal (4) 4
metaanalysis (4) 4
obesity - drug therapy (4) 4
patients (4) 4
pyrroles - administration & dosage (4) 4
usage (4) 4
acute coronary syndrome (3) 3
acute coronary syndrome - drug therapy (3) 3
adolescent (3) 3
angina (3) 3
angina pectoris (3) 3
anticholesteremic agents - adverse effects (3) 3
appetite depressants - therapeutic use (3) 3
body mass index (3) 3
cardiac patients (3) 3
cerebral infarction (3) 3
coronary artery disease (3) 3
coronary heart disease (3) 3
cyclobutanes - therapeutic use (3) 3
heart diseases (3) 3
heptanoic acids - therapeutic use (3) 3
hypercholesterolemia - complications (3) 3
injections, subcutaneous (3) 3
ischemia (3) 3
kexin (3) 3
mortality (3) 3
myocardial infarction (3) 3
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (199) 199
French (50) 50
Spanish (28) 28
Chinese (22) 22
German (15) 15
Korean (10) 10
Japanese (5) 5
Portuguese (4) 4
Polish (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Russian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2012, Volume 59, Issue 25, pp. 2344 - 2353
Objectives The primary objective of this study was to evaluate the low-density lipoprotein cholesterol (LDL-C)–lowering efficacy of 5 SAR236553/REGN727... 
Cardiovascular | Internal Medicine | statin | low-density lipoprotein cholesterol | safety | apolipoprotein-B | PCSK9 | SAR236553/REGN727 | hypercholesterolemia | CUTANEOUS VASCULITIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CHOLESTEROL | CARDIOVASCULAR OUTCOMES | LOW-DENSITY-LIPOPROTEIN | PREVENTION | REDUCTION | DISEASE | 14 RANDOMIZED-TRIALS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Time Factors | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - blood | Double-Blind Method | Proprotein Convertases - metabolism | Treatment Outcome | Anticholesteremic Agents - adverse effects | Drug Synergism | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Aged | Serine Endopeptidases - metabolism | Proprotein Convertase 9 | Care and treatment | Serine | Low density lipoproteins | Antibodies | Thrombin | Lipoprotein A | Cholesterol | Cardiovascular agents | Antilipemic agents | Viral antibodies | Complications and side effects | Hypercholesterolemia | Proteases | Monoclonal antibodies | Universities and colleges | Laboratories | Lipids | Triglycerides | Lipoproteins | Pain | Influenza | Patient safety | Population | Mutation | Clinical medicine | Diabetes | Statins
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2014, Volume 114, Issue 5, pp. 711 - 715
Journal Article
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 244, pp. 138 - 146
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 153 - 153
Background: Despite intensive statin therapy after acute coronary syndromes (ACS), the risk for recurrent cardiovascular (CV) events remains high and related... 
Cardiovascular | Internal Medicine | Clinical trials | Monoclonal antibodies | Usage | Coronary heart disease | Statins | Acute coronary syndromes | Low density lipoprotein
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 13, pp. E1620 - E1620
Background Low-density lipoprotein cholesterol (LDL-C) reduction significantly lowers cardiovascular risk in at-risk patients. 
Cardiovascular | Internal Medicine | Monoclonal antibodies | Care and treatment | Hypercholesterolemia | Comparative analysis | Proteases | Antilipemic agents | Low density lipoprotein | Cholesterol
Journal Article